Lawn, W., Hao, X., Konova, A. B., Haney, M., Cooper, Z. D., Van Dam, N., Glimcher, P., & Bedi, G. (2025). Value signals guiding choices for cannabis versus non-drug rewards in people who use cannabis near-daily. Psychopharmacology. https://doi.org/10.1007/s00213-025-06746-6

Chohan, M. O., Lewandowski, A. B., Siegel, R. N., O’Reilly, K. C., & Veenstra-VanderWeele, J. (2024). Adolescent chemogenetic activation of dopaminergic neurons leads to reversible decreases in amphetamine-induced stereotypic behavior. Molecular Brain, 17(1). https://doi.org/10.1186/s13041-024-01110-9

Simpson, E. H., Akam, T., Patriarchi, T., Blanco-Pozo, M., Burgeno, L. M., Mohebi, A., Cragg, S. J., & Walton, M. E. (2024). Lights, fiber, action! A primer on in vivo fiber photometry. Neuron, 112(5), 718–739. https://doi.org/10.1016/j.neuron.2023.11.016

Li, M., & Yang, G. (2024). A mesocortical glutamatergic pathway modulates neuropathic pain independent of dopamine co-release. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-45035-2

Stanley, A. T., Post, M. R., Lacefield, C., Sulzer, D., & Miniaci, M. C. (2023). Norepinephrine release in the cerebellum contributes to aversive learning. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-40548-8

Attia, E., & Steinglass, J. E. (2023). Psilocybin for anorexia nervosa: If it helps, let’s learn how. Med, 4(9), 581–582. https://doi.org/10.1016/j.medj.2023.08.003

Pagliaccio, D., Wengler, K., Durham, K., Fontaine, M., Rueppel, M., Becker, H., Bilek, E., Pieper, S., Risdon, C., Horga, G., Fitzgerald, K. D., & Marsh, R. (2023). Probing midbrain dopamine function in pediatric obsessive-compulsive disorder via neuromelanin-sensitive magnetic resonance imaging. Molecular Psychiatry, 28(7), 3075–3082. https://doi.org/10.1038/s41380-023-02105-z

Sosnowski, D. W., Jaffe, A. E., Tao, R., Deep-Soboslay, A., Shu, C., Sabunciyan, S., Kleinman, J. E., Hyde, T. M., & Maher, B. S. (2022). Differential expression of NPAS4 in the dorsolateral prefrontal cortex following opioid overdose. Drug and Alcohol Dependence Reports, 3, 100040. https://doi.org/10.1016/j.dadr.2022.100040

Dai, K. Z., Choi, I. B., Levitt, R., Blegen, M. B., Kaplan, A. R., Matsui, A., Shin, J. H., Bocarsly, M. E., Simpson, E. H., Kellendonk, C., Alvarez, V. A., & Dobbs, L. K. (2022). Dopamine D2 receptors bidirectionally regulate striatal enkephalin expression: Implications for cocaine reward. Cell Reports, 40(13), 111440. https://doi.org/10.1016/j.celrep.2022.111440

Weiss, M. C., Hibbs, J. E., Buckley, M. E., Danese, S. R., Leitenberger, A., Bollmann‐Jenkins, M., Meske, S. W., Aliano‐Ruiz, K. E., McHugh, T. W., Larson, S. L., Le, E. H., Green, N. L., Gilman, P. B., Kaklamani, V. G., Chlebowski, R. T., & Martinez, D. M. (2021). A Coala‐T‐Cannabis Survey Study of breast cancer patients’ use of cannabis before, during, and after treatment. Cancer, 128(1), 160–168. Portico. https://doi.org/10.1002/cncr.33906

Mahadevia, D., Saha, R., Manganaro, A., Chuhma, N., Ziolkowski-Blake, A., Morgan, A. A., Dumitriu, D., Rayport, S., & Ansorge, M. S. (2021). Dopamine promotes aggression in mice via ventral tegmental area to lateral septum projections. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-27092-z

Chukwueke, C. C., Nona, C. N., McPhee, M. D., Mansouri, E., Rubin-Kahana, D. S., Martinez, D., Boileau, I., Hendershot, C. S., & Le Foll, B. (2021). Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [11C]-(+)-PHNO study. Neuropsychopharmacology, 46(12), 2112–2120. https://doi.org/10.1038/s41386-021-01095-2